乳腺导管内乳头状瘤:低风险,但需谨慎处理
这项回顾性单中心研究分析了1999至2022年间179例超声引导下真空辅助乳腺活检(VABB)诊断为无 atypia 的良性乳头状瘤患者,其中32例接受手术,其余接受主动监测。手术组诊断低估率为9%(95%CI 2%-25%)。活检后残留病变未手术者复发风险显著高于无残留病变者(HR=6.76,p=0.015),而残留病变手术者复发风险与参照组无显著差异(HR=1.80,p=0.56)。
要点
- VABB诊断为无 atypia 的良性乳头状瘤后,手术组诊断低估率为9%(95%CI 2%-25%)。
- 活检后残留病变未手术者复发风险显著高于无残留病变者(HR=6.76,p=0.015)。
- 活检时年龄是复发的独立危险因素(HR=1.41,p=0.001),病变直径与复发无显著关联(HR=1.14,p=0.49)。
核心结论
- 对于VABB后无 atypia 的良性乳头状瘤,若病变未完全切除,复发风险似乎更高,手术切除可能是有必要的。
研究设计与样本
- 回顾性单中心研究,纳入1999至2022年间179例VABB诊断为无 atypia 的良性乳头状瘤患者,其中32例接受手术,其余接受主动监测;在手术组评估诊断低估,并评估活检后残留病变与后续手术管理及复发的关系。
关键影像表现/征象
- 研究队列中位年龄49岁,76%的病变通过VABB完全切除。
- 手术组中9%(95%CI 2%-25%)存在诊断低估,包括升级为原位癌或浸润癌。
- 126例有随访数据的患者中,9例(7%)发生同侧同象限复发事件。
诊断标准与关键数值
- 诊断低估定义为VABB后手术病理升级为原位癌或浸润癌,手术组发生率为9%(95%CI 2%-25%)。
- 多变量Fine and Gray回归模型中,活检后残留病变未手术者复发风险显著高于无残留病变者(HR=6.76,p=0.015)。
- 活检后残留病变手术者复发风险与参照组无显著差异(HR=1.80,p=0.56)。
- 活检时年龄是复发的独立危险因素(HR=1.41,p=0.001),病变直径与复发无显著关联(HR=1.14,p=0.49)。
临床应用与阅片要点
- 作者认为,对于VABB后未完全切除的乳头状瘤,手术切除可能是有必要的,因为复发风险似乎更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: This study aims to investigate the management of patients with breast papillomas without atypia diagnosed after ultrasound-guided vacuum-assisted breast biopsy (VABB).
MATERIALS AND METHODS: This retrospective, single-centre study analysed 179 patients diagnosed with benign papillomas without atypia between 1999 and 2022. Of these, 32 patients underwent surgery, while the remaining were managed with active surveillance. Diagnostic underestimation was assessed in the surgical group. The association between post-biopsy residual lesions and subsequent surgical management (surgery vs no surgery) with the incidence of recurrence was evaluated.
RESULTS: The study cohort had a median age of 49, with 76% of lesions completely removed via VABB. In the surgery group, 9% (95% CI: 2%-25%) had an underestimation, including upgrades to in situ or invasive carcinoma. Among the 126 patients with available follow-up data, 9 (7%) experienced recurrence events on the same side and in the same quadrant. In the multivariable Fine and Gray regression model, patients with post-biopsy residual lesions managed without surgery had a significantly higher recurrence risk than those without residual lesions (HR = 6.76, p = 0.015). Among patients with post-biopsy residual lesions who underwent surgery, the risk of recurrence was not significantly different from the reference group (HR = 1.80, p = 0.56). Additionally, age at biopsy was identified as an independent risk factor for recurrence (HR = 1.41, p = 0.001), whereas lesion diameter showed no significant association (HR = 1.14, p = 0.49).
CONCLUSIONS: Surgical resection may be warranted in cases of papillomas with incomplete removal at VABB, where recurrence risk appears to be higher.
引用
- Nicosia L, Mariano L, Mallardi C, et al. Intraductal papilloma of the breast: low risk, but handle with care. Radiol Med. 2025. PMID: 41131397. doi:10.1007/s11547-025-02120-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。